Prospective Assessment of the Rockall Risk ScoringSystem in Patients With Upper Gastrointestinal Hemorrhage

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02405286

Enrollment

Registered

2015-04-01

Start date

2014-05-31

Completion date

2014-12-31

Last updated

2015-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Bleeding

Brief summary

This study aimed to Assess the validity of the Rockall score for the prediction of rebleeding and death in patients with upper gastrointestinal bleeding.

Detailed description

This present study aimed to evaluate: Assess the validity of the Rockall score for the prediction of rebleeding and death in patients with upper gastrointestinal bleeding. 1- Technical Design: The technical design included research design, setting, subject and tools for data collection. Research design: A descriptive exploratory design was followed to achieve the aim of the study. Study setting: This study was conducted between Tropical department in AinShams university and Gastroenterology and Hepatology department in TheodorBilharz Research Institute. Sample size: EPI - INFO program version 6 was used for sample size calculation guided by power of the test = 80% - confidence level =95% and accepted margin of error = 5% and risk ratio = 5.5 - total sample minimum accepted = 50 This study included 50 recipients and done Tropical department in Ain Shams university and Gastroenterology and Hepatology department in . Theodore Bilharz Research Institute

Interventions

OTHERUpper gastrointestinal endoscopy

Upper gastrointestinal endoscopy, if stigmata of recent hemorrhage are seen, varices are either injected with ethanolamine or banded, depending on the clinical setting and availability .

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Adult Egyptian patients. * Patients with acute upper G.I hemorrhage. * Informed consent.

Exclusion criteria

* Refuse to participate in this study.

Design outcomes

Primary

Measure	Time frame
Clinical condition of the patients with accute upper gastrointstinal bleeding after 48 hours from endoscopy	48 hours

Secondary

Measure	Time frame
number of participants with variceal bleeding and other causes of upper gastrointestinal bleeding regarding the clinical condition after 48 hours	48 hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026